About this trial
This proof-of-principle study will determine if breathing an increased concentration of oxygen above the concentration in normal room air results in changes in the sensory and motor function in people with subacute or chronic, severe spinal cord injury (SCI).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Individuals with traumatic SCI with onset ≥3 months prior,
Between 18 - 65 yr old,
ASIA Impairment Scale at discharge classified as A, B or C,
Injury level between C5 and T10,
Disqualifiers
Frequent uncontrolled autonomic dysreflexia,
Uncontrolled high blood pressure,
Cardiac or cardiovascular disease,
Cancer,
Trial design
Crossover
Treatments tested in this trial
Pure oxygen (99%) from Praxair, Edmonton, DIN# 02014408
DrugParticipants will receive oxygen (99%) or room air (placebo) delivered through a face mask at a flow rate of 10 litres/min for 2 minutes. The participants will be exposed twice to both conditions over 4 experiments at a minimum of 2 week intervals between each testing session.
Treatment groups
Trial outcomes
Primary outcomes
Skin Sensation
Quantification using von Frey Hairs at three locations above and below the level of injury.
Skin Sensation
Quantification using von Frey Hairs at three locations above and below the level of injury.
Skin Sensation
Quantification using von Frey Hairs at three locations above and below the level of injury.
Skin Sensation
Quantification using von Frey Hairs at three locations above and below the level of injury.
Secondary outcomes
Reflex Excitability
Elicited by electrical stimulation of the skin on the arch of the foot and measured by surface electromyography (EMG).
Reflex Excitability
Elicited by electrical stimulation of the skin on the arch of the foot and measured by surface electromyography (EMG).
Reflex Excitability
Elicited by electrical stimulation of the skin on the arch of the foot and measured by surface electromyography (EMG).
Reflex Excitability
Elicited by electrical stimulation of the skin on the arch of the foot and measured by surface electromyography (EMG).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Alberta
Lead sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator